| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 799,500 | 798,600 | 794,400 | 748,900 |
| Cost of sales | 100,900 | 87,600 | 92,500 | 83,100 |
| Research and development | 127,500 | 134,000 | 149,000 | 103,500 |
| Selling, general, and administrative | 182,600 | 212,500 | 170,100 | 219,200 |
| Total operating expenses | 411,000 | 434,100 | 411,600 | 405,800 |
| Operating income | 388,500 | 364,500 | 382,800 | 343,100 |
| Interest income | 46,400 | 51,300 | 51,100 | 49,800 |
| Interest expense | 3,000 | 7,300 | 6,100 | 10,100 |
| Other income, net | 6,100 | -100 | -4,300 | 5,800 |
| Total other income, net | 49,500 | 43,900 | 40,700 | 45,500 |
| Income before income taxes | 438,000 | 408,400 | 423,500 | 388,600 |
| Income tax expense | 99,300 | 98,900 | 101,300 | 79,500 |
| Net income | 338,700 | 309,500 | 322,200 | 309,100 |
| Basic (in dollars per share) | 7.73 | 6.86 | 7.18 | 6.93 |
| Basic (in shares) | 43,800,000 | 45,100,000 | 44,900,000 | 44,600,000 |
| Diluted (in dollars per share) | 7.16 | 6.41 | 6.63 | 6.39 |
| Diluted (in shares) | 47,300,000 | 48,300,000 | 48,600,000 | 48,400,000 |
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)